An impressive list of expertise


Over the years, we have developed expertise over essential processes to serve the global consumers with highly innovative and effective products. This enables us to deliver exceptional quality and reliability as an innovator and manufacturer.


Generic Drug Development and Contract Research Services


We deliver high-quality and safe generic drugs to 30+ countries across five continents, driven by the rapid generic drug development and reliable contract research services.


Well-defined process of R&D to Commercial Manufacturing


Cutting-edge research and development, systematic scaling up, contract manufacturing to optimize overall productivity, thorough clinical trials for additional safety evaluation, and solid commercial manufacturing, all in a well-defined step-by-step process.


Experienced Regulatory Team &
Formulation Development


Our experienced regulatory teams conduct regular quality checks throughout the developmental process to ensure that our complicated generics are effective and safe. Robust API manufacturers back our Formulation Development, making sure our supply chain is reliable and unhindered in the long run.


Novel Drug Delivery Systems, Para IV/ NCE-1 & 505 B2 Development


We have efficient development capability to produce Novel Drug Delivery Systems along with Para IV, NCE-1 and 505 B2.

Manufacturing expertise at our high-tech plants

Atlanta Plant

We manufacture oral solids in the form of tablets and capsules at our state-of-the-art plant in Atlanta, USA.

UNIT I : ORAL SOLIDS


Dosage Forms Annual
Tablets 132.48 million
Capsules 38.40 million

Ahmedabad Plant

Our manufacturing plant at Ahmedabad, India is highly modern and advanced, with a massive production capability. We produce Small Vial Parenterals, Oral Solids & Liquids and Beta Lactum in millions annually, managed by an expert team.

UNIT II : GENERAL ORAL


Dosage Forms Annual
Tablets 499.20 million
Capsules 312 million
Dry Syrups 12.48 million
Liquid 12.48 million
ORS 62.40 million

UNIT III : SMALL VOLUME PARENTERALS


Dosage Forms Annual
Ampoules 16.64 million
Liquid Vials 16.64 million
Dry Powder Vials 16.64 million
Lyophilized Vials Under Installation

UNIT IV : BETA LACTUM ORAL


Dosage Forms Annual
Tablets 187.20 million
Capsules 312 million
Dry Syrups 12.48 million